Recent Company News

• 08:48 AM ET Apr 13, 2026
  

  Ascentage Pharma initiated recommend at China Galaxy Securities

• 02:16 PM ET Apr 10, 2026
  

  StreetAccount Summary: Notable Drug Events expected for the week of 12-Apr

• 11:11 PM ET Mar 23, 2026
  

  StreetAccount Summary - Trading higher/lower: Hong Kong mid-morning

• 09:00 AM ET Mar 26, 2026
  

  Transcript Intelligence: Ascentage Pharma Q4 Earnings Guidance

• 09:00 AM ET Mar 26, 2026
  

  Transcript Intelligence: Ascentage Pharma Q4 Earnings Themes

• 09:00 AM ET Mar 26, 2026
  

  Transcript Intelligence: Ascentage Pharma Q4 Earnings Q&A

• 06:36 PM ET Mar 25, 2026
  

  Ascentage Pharma reports FY net income attributable (CNY1.24B) vs FactSet (CNY807.0M) [4 est, (CNY1.09)-(38.5M)] (HK$44.14, 0.00)

• 08:05 PM ET Mar 17, 2026
  

  Ascentage Pharma to present four preclinical pipeline studies at AACR Annual Meeting 2026 (HK$46.50, 0.00)